As of Jun 24
| -2.45 / -5.66%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 49.26, with a high estimate of 60.47 and a low estimate of 35.00. The median estimate represents a +20.71% increase from the last price of 40.81.
The current consensus among 31 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.